
Novartis’ fourth quarter sales have faded slightly as growth in pharmaceuticals is beaten back by generic competition, and the firm …

Sanofi is looking to diversify and is even considering buying into the consumer and animal health markets according to its …
Novartis is overseeing the construction of a biotechnology facility in Singapore that is the result of a $500m investment injection. …

Novartis’ long-standing chief executive and chairman, Daniel Vasella is to step down from his dual position to focus upon his …
The head of Novartis’ pharmaceutical business Joe Jimenez has set out his plans to make the division more efficient and …